A global platform advancing pharmaceutical collaboration, innovation, and exports—powering healthcare and connecting markets worldwide
The savings will be fully reinvested to support new product launches and its pipeline across multiple therapeutic areas
Moderna's updated COVID-19 mRNA vaccine will be available for the 2025-2026 vaccination season, pending a European Commission authorization decision
Most recently he served as Chief Operating Officer at Bharat Serums and Vaccines
The Medical Countermeasures Strategy focuses on strengthening the EU’s preparedness for health crises
Enhance strategies to drive sustainability, global Reach and digital transformation for a trillion-dollar future
mRNA-1010 demonstrated superior relative vaccine efficacy
The partnership combines Boehringer’s expertise in canine cardiology with Eko’s digital stethoscopes and AI algorithms
The Board of Directors of the company recommends a final dividend of Rs. 42 per equity share for the 12 months period ended March 31, 2025
ekincare has raised a total funding of $22M since 2015 till date
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
